125 related articles for article (PubMed ID: 36690076)
1. miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways.
Sabater L; Gossart JB; Hernandez I; Rico D; Blanchard A; Borthwick LA; Fisher AJ; Majo J; Jiwa K; Collins A; Abbate G; Oakley F; Mann DA; Mann J
Am J Pathol; 2023 Apr; 193(4):417-429. PubMed ID: 36690076
[TBL] [Abstract][Full Text] [Related]
2. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
[TBL] [Abstract][Full Text] [Related]
3. RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway.
Calabrese F; Lunardi F; Tauro V; Pezzuto F; Fortarezza F; Vedovelli L; Faccioli E; Balestro E; Schiavon M; Esposito G; Vuljan SE; Giraudo C; Gregori D; Rea F; Spagnolo P
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328744
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis.
Kamp JC; Neubert L; Stark H; Hinrichs JB; Boekhoff C; Seidel AD; Ius F; Haverich A; Gottlieb J; Welte T; Braubach P; Laenger F; Hoeper MM; Kuehnel MP; Jonigk DD
Cells; 2022 Feb; 11(4):. PubMed ID: 35203313
[TBL] [Abstract][Full Text] [Related]
6. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
7. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis.
Herrera J; Beisang DJ; Peterson M; Forster C; Gilbertsen A; Benyumov A; Smith K; Korenczuk CE; Barocas VH; Guenther K; Hite R; Zhang L; Henke CA; Bitterman PB
Am J Respir Crit Care Med; 2018 Aug; 198(4):486-496. PubMed ID: 29579397
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
[TBL] [Abstract][Full Text] [Related]
9. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
10. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis.
Huang C; Yang Y; Liu L
Physiol Genomics; 2015 Oct; 47(10):463-9. PubMed ID: 26269497
[TBL] [Abstract][Full Text] [Related]
11. The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis.
Díaz-Piña G; Ordoñez-Razo RM; Montes E; Páramo I; Becerril C; Salgado A; Santibañez-Salgado JA; Maldonado M; Ruiz V
Lung; 2018 Aug; 196(4):393-400. PubMed ID: 29637273
[TBL] [Abstract][Full Text] [Related]
12. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
13. A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Zhao T; Gong B; Luo S; Zhang R; Zhang L; Huang Y; Gao H; Gong T
Acta Biomater; 2023 Sep; 167():574-582. PubMed ID: 37356783
[TBL] [Abstract][Full Text] [Related]
14. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
Dakhlallah D; Batte K; Wang Y; Cantemir-Stone CZ; Yan P; Nuovo G; Mikhail A; Hitchcock CL; Wright VP; Nana-Sinkam SP; Piper MG; Marsh CB
Am J Respir Crit Care Med; 2013 Feb; 187(4):397-405. PubMed ID: 23306545
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
17. miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1.
Li S; Geng J; Xu X; Huang X; Leng D; Jiang D; Liang J; Wang C; Jiang D; Dai H
PLoS One; 2016; 11(3):e0150418. PubMed ID: 26953888
[TBL] [Abstract][Full Text] [Related]
18. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.
Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Miyajima M; Mishina T; Yamada G; Otsuka M; Hasegawa T; Kojima T; Niki T; Watanabe A; Takahashi H; Sakuma Y
Lab Invest; 2017 Mar; 97(3):232-242. PubMed ID: 27941755
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
20. Searching for airways biomarkers useful to identify progressive pulmonary fibrosis.
Soccio P; Moriondo G; Scioscia G; Leo V; Tondo P; Salerno L; Palange P; Barbaro MPF; Lacedonia D
BMC Pulm Med; 2023 Oct; 23(1):407. PubMed ID: 37884953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
